GLAXOSMITHKLINE PLC GSK (NYSE) $ 39.00 Change: +3.92 +10.05% | Volume: 2,666,940
Sponsored by Click here!

GLAXOSMITHKLINE - Fundamental Profile

Company Information

Ticker Symbol: GSK
Exchange: NYSE
Contact Info:
CEO/President:
Industry: Medical - Drugs / Standard Industry Code: 2834
Description: GlaxoSmithKline is one of the world\'s leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.

Share Information

Shares Outstanding: 2,664,260 (000) Market Value: 91,917,216 ($000)
Percentage of Inst.Shareholders: 11.94% Number of Inst.Shareholders: 10.00%
Last Quarter Sales: 11583.52 ($Mil.) Last Quarter Net Income: 2851.51 ($Mil.)
Last Quarter EPS: N/C P/E Ratio: 11
Most Recent Earnings: 1.02 on 04/23/08 Earnings Per Share: 2.29
Most Recent Split: Annual Dividend Rate: 2.2
Most Recent Dividend: 0.519 on 07/30/08 Annual Dividend Yield: 6.26%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

PFIZER INC -40.50 15.14
JOHNSON AND JOH -19.70 55.85
MERCK CO INC -54.70 26.23
BRISTOL MYERS S -39.70 17.56
SCHERING PLOUGH -58.90 13.36